InsidersTradesSigma
Follow the 创业慧康 share price and the full insider trade history of the company, a listed equity based in China. Shares are quoted on the CN market, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 创业慧康 has recorded 4 insider filings. Market capitalisation: €5.2bn. The latest transaction was reported on 4 January 2023 (Sale). Among the most active insiders: 葛航. Every trade is openly available.
4
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
€47m
4 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 25,768 of 29,064 companies
23.4
score / 100
Value22
Quality25
FCF yld-3.7%
Earn yld-7.7%
EV/EBITDA·
ROE-11%
Gross mgn36%
Net mgn-38%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 4 January 2023
关于 创业慧康
创业慧康是一家在健康和制药领域运营的公司，在XSHE市场上市。它专注于开发创新解决方案以提升医疗保健服务。